AMRUTANJAN HEALTH CARE LTD.

NSE : AMRUTANJANBSE : 590006ISIN CODE : INE098F01031Industry : Pharmaceuticals & DrugsHouse : Amrutanjan
BSE637.90-6.05 (-0.94 %)
PREV CLOSE ( ) 643.95
OPEN PRICE ( ) 627.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3276
TODAY'S LOW / HIGH ( )627.75 644.50
52 WK LOW / HIGH ( )556.05 774.75
NSE638.20-5.2 (-0.81 %)
PREV CLOSE( ) 643.40
OPEN PRICE ( ) 646.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 638.20 (14)
VOLUME 26791
TODAY'S LOW / HIGH( ) 633.00 646.65
52 WK LOW / HIGH ( )563.9 775.45
( in Million)
Select year
ParticularsMar2016Mar2015Mar2014Mar2013Mar2012
Profit Before Tax326.83241.49193.80154.74161.20
Adjustment-13.063.2835.1130.5427.32
Changes In working Capital8.1132.1619.13-43.80-101.32
Cash Flow after changes in Working Capital321.89276.93248.05141.4987.21
Cash Flow from Operating Activities206.99183.15174.4886.2036.22
Cash Flow from Investing Activities41.61-48.95164.9177.31144.99
Cash Flow from Financing Activities-131.04-119.27-139.16-142.63-273.09
Net Cash Inflow / Outflow117.5614.93200.2320.87-91.88
Opening Cash & Cash Equivalents306.67291.7391.5070.62244.27
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent424.23306.67291.7391.50152.39

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.